AEON Biopharma (NASDAQ:AEON – Free Report) had its price objective reduced by HC Wainwright from $18.00 to $6.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a buy rating on the stock. AEON Biopharma Stock Down 2.5 % AEON traded down $0.04 during midday trading on Wednesday, reaching $1.54. […]
HALO Finances Crestone & Atalaya s Acquisition and Lease Back of Two Midlife Airbus A320s
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Banks Rent Rivals Balance Sheets to Skirt Capital Rules
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
(Bloomberg) For years, Barclays Plc struggled with what to do about its US credit-card business. It was a cash generator, cranking out a steady stream of revenue, and yet it was costly to run because of the way regulators force banks to set aside capital as a buffer against losses.Most Read from BloombergTesla Axes Supercharger Team in Blow to Broader EV MarketNYPD Arrests Over 300 Protesters in Crackdown on College CampusesThe Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entir